ArticleJNCI cancer spectrum2022

Chemotherapy Regimens Received by Women With BRCA1/2 Pathogenic Variants for Early Stage Breast Cancer Treatment.

Allison W Kurian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.